Recent research on bioactive xanthones from natural medicine: Garcinia hanburyi
- PMID: 26152816
- PMCID: PMC4508296
- DOI: 10.1208/s12249-015-0339-4
Recent research on bioactive xanthones from natural medicine: Garcinia hanburyi
Abstract
Garcinia hanburyi, a tropical plant found in south Asia, has a special long history in the development of both medicine and art. This review mainly focuses on the pharmacy research of the bioactive compounds from the plant in recent years. Preparative and analysis separation methods were introduced. Moreover, the chemical structure of the isolated compounds was included. The studies of biological activities of the caged xanthones from the plant, including antitumor, anti-HIV-1, antibacterial, and neurotrophic activities, were reviewed in detail. Furthermore, the mechanisms of its antitumor activity were also reviewed. As mentioned above, some of the xanthones from G. hanburyi can be promising drug candidates, which is worth studying. However, we still need much evidence to prove their efficacy and safety. So, further research is critical for the future application of xanthones from G. hanburyi.
Figures
Similar articles
-
Cytotoxic polyprenylated xanthones from the resin of Garcinia hanburyi.J Nat Prod. 2009 Jan;72(1):117-24. doi: 10.1021/np800460b. J Nat Prod. 2009. PMID: 19072548
-
Antibacterial caged-tetraprenylated xanthones from the fruits of Garcinia hanburyi.Chem Pharm Bull (Tokyo). 2005 Jul;53(7):850-2. doi: 10.1248/cpb.53.850. Chem Pharm Bull (Tokyo). 2005. PMID: 15997152
-
Three new xanthones from the resin of Garcinia hanburyi.Planta Med. 2013 Jun;79(9):792-6. doi: 10.1055/s-0032-1328537. Epub 2013 May 13. Planta Med. 2013. PMID: 23670620
-
Caged Polyprenylated Xanthones in Garcinia hanburyi and the Biological Activities of Them.Drug Des Devel Ther. 2023 Dec 5;17:3625-3660. doi: 10.2147/DDDT.S426685. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 38076632 Free PMC article. Review.
-
Caged Garcinia xanthones: development since 1937.Curr Med Chem. 2009;16(28):3775-96. doi: 10.2174/092986709789104993. Curr Med Chem. 2009. PMID: 19747141 Review.
Cited by
-
30-hydroxygambogic acid increases the efficacy of cisplatin in an HPV+ head and neck cancer in vivo model.BMC Cancer. 2025 Aug 1;25(1):1251. doi: 10.1186/s12885-025-14638-3. BMC Cancer. 2025. PMID: 40745291 Free PMC article.
-
Mangostanaxanthones III and IV: advanced glycation end-product inhibitors from the pericarp of Garcinia mangostana.J Nat Med. 2017 Jan;71(1):216-226. doi: 10.1007/s11418-016-1051-8. Epub 2016 Oct 13. J Nat Med. 2017. PMID: 27738860
-
Gambogic amide inhibits angiogenesis by suppressing VEGF/VEGFR2 in endothelial cells in a TrkA-independent manner.Pharm Biol. 2021 Dec;59(1):1566-1575. doi: 10.1080/13880209.2021.1998140. Pharm Biol. 2021. PMID: 34767490 Free PMC article.
-
Synergistic Effect of 1,3,6-Trihydroxy-4,5,7-Trichloroxanthone in Combination with Doxorubicin on B-Cell Lymphoma Cells and Its Mechanism of Action Through Molecular Docking.Curr Ther Res Clin Exp. 2020 Jan 30;92:100576. doi: 10.1016/j.curtheres.2020.100576. eCollection 2020. Curr Ther Res Clin Exp. 2020. PMID: 32123546 Free PMC article.
-
The protective effect of natural medicines in rheumatoid arthritis via inhibit angiogenesis.Front Pharmacol. 2024 May 31;15:1380098. doi: 10.3389/fphar.2024.1380098. eCollection 2024. Front Pharmacol. 2024. PMID: 38881875 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials